// App-Quantinova.ai

: A FLEXIBLE THERAPEUTIC STRATEGY FOR LEUKEMIA USING EX-VIVO EXPANDED T CELLS COMBINED WITH BISPECIFIC ANTIBODIES

Researchers

Presenter

  • Jose Golay

Principal Investigators

  • Elisa Gotti

  • Antonella Interdonato

  • Rut Valgardsdottir

  • Alessandro Rambaldi

  • Martino Introna

Medical Centers

  • Center of Cellular Therapy 'G. Lanzani',ASST Papa Giovanni XXIII,Bergamo,Italy;Fondazione per la Ricerca Ospedale Maggiore,Bergamo,Italy

  • Center of Cellular Therapy 'G. Lanzani',ASST Papa Giovanni XXIII,Bergamo,Italy

  • Department of Oncology and Hematology,Università degli Studi di Milano,Milano,Italy;Hematology and Bone Marrow Transplantation Unit,ASST Papa Giovanni XXIII,Bergamo,Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Cluster of Differentiation 107 Antigen-Like Family Member A

  • Cluster of Differentiation 19

Drug/Treatment

  • Interferon Gamma

  • Blinatumomab

  • Interleukin

  • Interferon

  • rhIL-2

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved